A new study identified demographics that characterize a higher risk of conscientious vaccination exemptions for children in Texas.
Sarilumab is currently used to treat adult patients with moderately-to-severely active rheumatoid arthritis after treatment with at least 1 disease-modifying antirheumatic drug.
President Trump and his health advisors announced a 15-day plan to slow the spread of COVID-19.
Empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) is being investigated to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.
A clinical trial evaluating an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, has been launched, with volunteers receiving the first injection on March 16.
Approximately 1 million individuals are living with multiple sclerosis in the United States, according to the National MS Society.
Telehealth advancements in response to COVID-19 reveal the importance of digital health delivery during outbreaks.
Walgreens, CVS Health, and Target said they will start providing coronavirus disease (COVID-19) testing in their parking lots.
Walk into a pharmacy in 2030 and there’s a good chance you’ll see a pharmacist. And there’s a good chance the pharmacist will have little or nothing to do with dispensing.
An update on how COVID-19 is affecting pharmacy.